Abstract: Myxobacteria are an excellent source of novel secondary metabolites with a range of biological activities. This review details the synthesis of several examples of these natural products. The total synthesis of all the members of the crocacin family is presented where the stereochemistry of the stereotetrad was set via a tin-mediated syn-aldol reaction followed by selective anti-reduction. The other key step in the route to crocacins A, B, and D was the introduction of the enamide functionality by acylation of an enecarbamate. A formal synthesis of apicularen A is also discussed, which involved a base-induced macrolactonization reaction and a transannular oxy-Michael cyclization to secure the tetrahydropyran ring. Finally, the total synthesis of deshydroxyajudazol B is summarized. This route details a modified approach to the 2,4-disubstituted oxazole, and a Diels-Alder reaction followed by aromatization was utilized to form the isochromanone moiety. A highly efficient Sonogashira coupling followed by partial reduction then gave deshydroxyajudazol B.
INTRODUCTION
Myxobacteria are Gram-positive bacteria that are at the interface between single and multicellular organisms [1] . They predominantly live in soil rich in organic matter and are found mostly in semiarid, warm areas. Thus far, some 7500 strains of myxobacteria have been identified, and these microorganisms can be distinguished readily from other bacteria in two main ways. Firstly, they move by gliding or creeping over a solid surface and can cover a culture plate completely in 6-8 days. The second unique difference is their astonishing life cycle. Upon starvation, these single-celled organisms congregate to produce fruiting bodies from 20 to 1000 μm in size with complex structures [1] . To date, there is no comprehensive explanation for this cooperative morphogenesis, and understanding this process is the subject of intense investigation in a number of laboratories. Myxobacteria are also a rich source of potentially useful secondary metabolites with more than 100 basic structural types with around 500 structural variants [2] . The vast majority of secondary metabolites isolated have been described by the Höfle and Reichenbach research groups in Germany, and many exhibit antifungal, antibacterial, cytostatic, and cytotoxic activity. Several examples of the diverse array of these metabolites are shown in Fig. 1 . The species Sorangium cellulosum has the largest bacterial genome sequenced to date (~13 million base pairs) and produces the potent anticancer compound epothilone B (1) [3, 4] . Ixabepelone, the less toxic synthetic macrolactam derivative of epothilone B (1), is currently used as a
Total synthesis of the crocacins A-D
An early series of targets within the group were the crocacins A (3), B (7), C (8) , and D (9) . As mentioned, this family of natural products was isolated from C. crocatus and show promise as lead compounds for agrochemicals [14] . The crocacins A (3), B (7), and D (9) all contain an interesting Z-enamide functionality and a common polyketide fragment represented in the simplest example, crocacin C (8). These compounds have attracted the interest of a number of synthetic groups [15] , and our approach to this family of natural products [16] is exemplified by the retrosynthesis of crocacin D (9) as shown in Fig. 2 . We envisaged that Z-enamide in 9 could be formed by acylation [17] of the anion derived from N-acylenamine or enecarbamate 11 with acid chloride 10. A simple peptide coupling with glycine methyl ester would then afford the dipeptide and removal of the trimethylsilylethoxycarbonyl (TEOC) group would provide the target crocacin D (9) . The syn, anti, anti-stereotetrad in acid chloride 10 would be secured by a syn-aldol reaction to form the C-C bond and stereoselective anti reduction whilst the E,E-diene could be introduced by a Stille cross-coupling reaction to forge the C-C bond. Enecarbamate 11 could be synthesized by Curtius rearrangement of a N-acylazide followed by treatment of the labile resultant isocyanate with triethylsilylethanol.
The total synthesis of the simplest example of these compounds, crocacin C (8) , is shown in Scheme 1. This short route begins with a Paterson-type syn-aldol [18] reaction between the Z(O) tin enolate derived from ketone 13 and cinnamaldehyde. The syn-product 14 was formed in high yield and with good stereocontrol. Diastereoselective anti reduction of 14 produced the syn, anti, anti-stereo tetrad diol which on methylation and removal of the silicon protecting group gave alcohol 16. Oxidation followed by vinylstannylation [19] afforded the vinyl stannane 17 in excellent yield. Stille cross-coupling [20] with the iodide 18 then gave crocacin C (8) [21] . This first total synthesis confirmed the absolute configuration of this family of compounds.
The synthesis of crocacin D was then achieved as outlined in Scheme 2 and begins with the synthesis of the acid chloride 10. Stille coupling between stannane 17 and iodide 19 afforded ester 20. Hydrolysis followed by formation of the acid chloride via the sodium salt of the acid then gave 10. The synthesis of the enecarbamate fragment 11 began with treatment of unsaturated acid 21 with diphenyl phosphoryl azide (DPPA) and NaH to give the N-acylazide 22 with minimal isomerization of Z-alkene. Heating 21 in toluene induced Curtius rearrangement to give the intermediate isocyanate, which was immediately treated with trimethylsilylethanol in boiling toluene to afford the required enecarbamate 11. Treatment of 11 with base produced the anion, which was allowed to react with acid chloride 10 to give the protected enamide 23 in 30 % yield starting from ester 19. Removal of the tert-butyldimethylsilyl (TBS) group in the presence of the TEOC protecting group was achieved with HFؒpyri-dine buffered with pyridine to afford the alcohol 24 in excellent yield. Two-stage oxidation of the alcohol 24 to the corresponding acid was achieved with Dess-Martin periodinane followed by NaClO 4 . Peptide coupling with glycine methyl ester (12) The total synthesis of crocacin A (3) followed a similar route to that described for crocacin D (9) (Scheme 3). Key to the approach was the effective synthesis of the skipped Z,Z-enamide system. This began with the copper-mediated coupling [22] of the terminal alkyne 27 and chloride 26 to afford sensitive diyne 28, which was immediately converted into the diene 29 system by partial reduction of the diyne using hydrogen gas and P-2 nickel catalyst [23] . Other methods such as Lindlar reduction proved unreliable. Oxidation to the acid 30 followed by conversion to the azide 31 set the stage for Curtius rearrangement in boiling toluene followed by addition of trimethylsilylethanol to give dienecarbamate 32. Deprotonation and acylation with acid chloride 10 gave the enamide 33, which could be converted into alcohol 34 by treatment with HFؒpyridine. Two-stage oxidation and peptide coupling with 12 yielded 36 along with some amount of the 6E-alkene isomer 35 produced by base-promoted isomerization. The unwanted isomer 35 could be separated from 36 by flash chromatography. Finally, expo- sure of 36 to TBAF allowed for removal of the TEOC group to provide crocacin A (3) in 57 % yield [24] . Attempted base hydrolysis of crocacin A (3) failed to provide crocacin B (7) so an ester protecting group was utilized (Scheme 4). Thus, treatment of acid 37 derived from alcohol 34 with the trimethylsilylethyl (TMSE) ester of glycine 38 and N,N'-dicyclohexylcarbodiimide/dimethylaminopyridine (DCC/DMAP) gave the dipeptide 40 and 6E-isomer 39 in a ratio now slightly favoring the undesired isomer 39. Treatment of 40 with TBAF effected removal of the carbamate and ester protecting groups to afford crocacin B (7) for the first time.
Formal total synthesis of apicularen A
The myxobacteria metabolite apicularen A (5) is very similar to marine sponge metabolite salicylihalamide A (Fig. 3) . Thus, we were attracted to apicularen A (5) as a target [25, 26] following our formal synthesis of salicylihalamide A [27, 28] . We envisaged that a formal total synthesis of 5 could be achieved by the production of known intermediate 41 [29] . The macrolactonization reaction involves deprotonation of the 13-hydroxy group followed by attack at the carbonyl carbon of the 1,3-dioxanone with a loss of acetone. Methylation of the resultant phenolate anion followed by deprotection and allylic oxidation gives the macrolactones 42 or 43. Again, the stereo chemistry at the C11 stereocenter is not relevant since C11 is destroyed upon oxidation. The macrolactone precursor alkenes 44 or 45 could be then secured by a Stille cross-coupling between benzyl bromide 46 and either stannane diastereoisomer 47 or 48.
If the cyclization of the enone 42 is conducted under conditions favoring thermodynamic control, then the stereoisomer that is lowest in energy should be preferred. Initial MM2 (PC Model) calculations (Fig. 4) showed that the desired 9,13-trans-13,15-syn-isomer A (twist boat conformer with a truncated enamide side chain) with the natural product stereochemistry was favored over the alternative isomers B, C, and D. These calculations suggested that isomer A would be favored in a ratio greater than 99:1 (average energy difference ~ 17.2 kJ mol -1 ) ratio at 20 °C. In addition, the C13 and C9 stereocenters are set by an oxy-Michael retro-Michael sequence so that the stereochemistry at both these centers is controlled solely by the C15 stereocenter. Specifically, both enone diastereoisomers 42 and 43 can undergo epimerization at C13, which should ensure the required stereochemistry under equilibration conditions. Stille coupling between stannane 47 and bromide 46 afforded alkene 52 in good yield (Scheme 6). Macrolactonization was effected by treatment of 52 with NaH, and methylation of the intermediate phenolate anion gave the methyl ether. Removal of the silicon protecting groups and selective allylic oxidation with MnO 2 gave the enone 42. Transannular cyclization was then achieved using Amberlyst 15 acidic ion-exchange resin [32] to afford the pyranone 54 as a single stereoisomer. The structure of 54 was confirmed by X-ray crystallography and comparison to literature data. Reduction of the ketone was difficult to achieve stereoselectively but was effected in high yield with NaBH 4 (ratio 1:1). The incorrect isomer was converted into the desired one via Mitsunobu inversion [33] . Finally, demethylation with 9-iodo-9-BBN gave compound 41, which had physical data identical to that reported [29, 34, 35] . This completed the formal total synthesis of apicularen A, which utilized a transannular oxy-Michael reactions as the key step [36] .
Total synthesis of deshydroxyajudazol A
The ajudazols A (4) and B (55) were isolated from the same myxobacterium C. crocatus that produces the crocacins and have an interesting biosynthesis (Scheme 7) [37] . The putative biosynthetic intermediate is proposed to be deshydroxyajudazol B (56). This intermdiate undergoes selective oxidation at C8 mediated by the cytochrome P450 enzyme AjuJ (encoded by the gene ajuJ) to produce ajudazol B (55). Alternatively, C15 oxidation and elimination by AjuI produces deshydroxyajudazol A (57), which is then finally oxidized by the enzyme AjuJ (encoded by the gene ajuI) to form ajudazol A (4), however, ajudazol B (55) is not a substrate for AjuI and is therefore not converted directly into 4. Indeed, the deshydroxyajudazols A and B have been detected in trace amounts in extracts of C. crocatus and have been observed in larger amounts in extracts from mutants in which the genes ajuI and ajuJ were knocked out. We were intrigued by this biosynthesis and elected to synthesize the putative biosynthetic intermediate and trace natural product deshydroxyajudazol B (56) [38, 39] . The relative anti, antistereo chemistry for the C8-10 stereotriad was determined by 1 H NMR analysis, but the configuration at C15 is unknown and the absolute stereochemistry remains to be confirmed [8] .
Our retrosynthetic analysis of the 9R,10S,15R-stereoisomer of deshydroxyajudazol B (56) is shown in Scheme 8. The C18-C19 bond would be formed by a Sonogashira coupling [40] between eastern fragment vinyl iodide 58 [41] and western fragment alkyne 59. The oxazole in 59 could be secured by a modified approach involving an acylation with acid 61 [42] , an O,N-acyl shift to form an amide, and oxidation followed by subsequent cyclodehydration to give the 2,4-disubstituted oxazole (vide infra). The isochromanone in 60 could be formed by an intramolecular Diels-Alder reaction (IMDA) of the diene ester 62 followed by aromatization [34] .
heating in toluene in a sealed tube at 180 °C. Aromatization was induced with dichlorodicyano-pbenzo quinone (DDQ) to afford bromide 67 [34] . Bromine oxygen exchange was best achieved via Pd-catalyzed cross-coupling with pinacolborane using Buchwald's SPhos ligand [49] followed by oxidation, and hydrolysis provided phenol 68, which was protected as the p-methoxybenzyl (PMB) ether 69. Hydroboration of the terminal alkene in 69 proved troublesome so we turned to the use of Wilkinson's catalyst and pinacolborane [50] , which gave alcohol 70 in a reproducible manner. Oxidation and Wittig extension then gave the alkene 60.
Dihydroxylation of 60 gave the diol 71 as a mixture of diastereoisomers in excellent yield (Scheme 11) [51] . We then applied the modified approach described above to secure the 2,4-disubstituted oxazole present in the ajudazols. Selective acylation of the primary alcohol in 71 with optically pure acid 61 [41] afforded the ester 72 in good yield. Azide displacement of the secondary alcohol was achieved using a Mitsunobu protocol using the stable crystalline Zn(N 3 ) 2 ؒ2pyridine [52] as the azide source. Reduction of the resultant azide 73 was effected with 1,3-propanedithiol [53] , and treatment with base induced the O,N-shift [43] to give the amide 74. Parikh-Doering oxidation of the primary alcohol and cyclization was effected by treatment with 1,2-dibromotetrachloroethane and PPh 3 in the presence of hindered base 2,6-di-tert-butyl-4-methylpyridine [44b], and dehydrohalogenation with Hünigs base furnished the oxazole 75 in 67 % yield overall from the amido alcohol 76. It should be noted that no racemization of the C15 stereocenter was observed in this process. Owing to problems with removal of the PMB at a latter stage of the synthesis, the free phenol was deprotected at this stage by treatment with CSA to give the western fragment 59.
The completion of the total synthesis of deshydroxyajudazol B (56) is shown in Scheme 12. The requisite eastern fragment vinyl iodide was synthesized from iodide 76 [40] . Oxidation and Wittig reaction using a stabilized ylide gave ester 77. Reduction followed by formation of the bromide and substitution with methylamine gave secondary amine 78. Peptide coupling with acid 79 yielded the eastern fragment 58. Sonogashira coupling between iodide 58 and alkyne 59 was extremely efficient at forming the C18-C19 bond to give enyne 80 in high yield. The partial reduction of the alkyne in 80 proved somewhat difficult. We found that partial reduction could be achieved with P-2 Ni and H 2 gas in the presence of ethyl diazoacetate (EDA), however, some over-reduction was observed. High-performance liquid chromatography (HPLC) allowed for the separation of the desired product 56 from over-reduced compound and starting material. There was no physical data to compare directly with our synthetic deshydroxyajudazol B (56) however, this compound displayed NMR spectral data similar to that for the eastern half of ajudazol B (55) [8] and the western half of deshydroxyajudazol A (57) [37] . Due to the absence of any chiroptical data for 56, the absolute configuration of this family of compounds remains to be determined.
In this review, we have detailed the synthesis of some examples of myxobacteria metabolites. Ongoing research continues in our laboratories toward other targets from this life form, including the ajudazols A (4) and B (55), spirangien A (2), and rhizopodin (6) .
